PART I Overview XBiotech Inc. (XBiotech or the Company) is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies for treating a variety of diseases. XBiotech was incorporated in Canada on March22, 2005. The Companys Internet address is www.xbiotech.com . The Company makes available free of charge on or through its website its annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and amendments to those reports filed or furnish...
Q2 FY2026 — expected 2026-09-07
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-13 | 2025-12-31 | 0001171843-26-001561 | EDGAR | 36K words |
| 2025-03-18 | 2024-12-31 | 0001171843-25-001527 | EDGAR | — |
| 2024-03-15 | 2023-12-31 | 0001171843-24-001382 | EDGAR | — |
| 2023-03-15 | 2022-12-31 | 0001171843-23-001705 | EDGAR | — |
| 2022-03-15 | 2021-12-31 | 0001171843-22-001904 | EDGAR | — |
| 2021-03-16 | 2020-12-31 | 0001171843-21-001828 | EDGAR | — |
| 2020-03-16 | 2019-12-31 | 0001171843-20-001761 | EDGAR | — |
| 2019-03-14 | 2018-12-31 | 0001171843-19-001708 | EDGAR | — |
| 2018-03-16 | 2017-12-31 | 0001171843-18-002043 | EDGAR | — |
| 2017-03-16 | 2016-12-31 | 0001171843-17-001571 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-12 | 2025-09-30 | 0001171843-25-007233 | EDGAR | 13K words |
| 2025-08-13 | 2025-06-30 | 0001171843-25-005368 | EDGAR | — |
| 2025-05-14 | 2025-03-31 | 0001171843-25-003178 | EDGAR | — |
| 2024-11-13 | 2024-09-30 | 0001171843-24-006336 | EDGAR | — |
| 2024-08-12 | 2024-06-30 | 0001171843-24-004689 | EDGAR | — |
| 2024-05-10 | 2024-03-31 | 0001171843-24-002746 | EDGAR | — |
| 2023-11-09 | 2023-09-30 | 0001171843-23-006944 | EDGAR | — |
| 2023-08-11 | 2023-06-30 | 0001171843-23-005261 | EDGAR | — |
| 2023-05-10 | 2023-03-31 | 0001171843-23-003144 | EDGAR | — |
| 2022-11-09 | 2022-09-30 | 0001171843-22-007285 | EDGAR | — |
| 2022-08-10 | 2022-06-30 | 0001171843-22-005546 | EDGAR | — |
| 2022-05-10 | 2022-03-31 | 0001171843-22-003510 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2025-12-09 | 0001171843-25-007836 | EDGAR | 1K words |
| 2025-10-03 | 0001171843-25-006266 | EDGAR | — |
| 2025-09-02 | 0001171843-25-005673 | EDGAR | — |
| 2025-06-24 | 0001171843-25-004066 | EDGAR | — |
| 2025-04-07 | 0001171843-25-002067 | EDGAR | — |
| 2025-04-01 | 0001171843-25-001876 | EDGAR | — |
| 2024-12-31 | 0001171843-24-007128 | EDGAR | — |
| 2024-06-20 | 0001171843-24-003541 | EDGAR | — |
| 2024-01-04 | 0001171843-24-000056 | EDGAR | — |
| 2023-06-23 | 0001171843-23-004095 | EDGAR | — |
136 total filings indexed. 104 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001626878 |
| Ticker | XBIT |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | A1 |
| Website | http://www.xbiotech.com |
| Listed | 2015-04-15 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report